• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Compounds of formula; <CHEM> in which, R1 is hydrogen, methyl, methoxy, ethoxy, amino or ureido, R2 is hydrogen or an alkyl group having 1-3 carbon atoms, R3 is trifluoromethyl or halogen, T is oxygen or sulphur, and m is 0 or 1, and salts thereof with pharmaceutically acceptable acids, are described. These compounds have a strong and selective antiagressive activity. They can be prepared in a manner known for analogous compounds and be processed to the usual compositions.
    公开号:SU1039442A3
    申请号:SU802890551
    申请日:1980-02-27
    公开日:1983-08-30
    发明作者:Хайнц Хэк Ханс；Корнелиус Хиллен Федо
    申请人:Дюфар Интернэшнл Рисерч Б.В. (Фирма)；
    IPC主号:
    专利说明:

    00 with
    four; ethers add ether until crystallisation begins, 1-2 M-aminocarbolamine 7 (3-chlorophenyl piperazine hydrochloride, mp 186-187 0 is obtained. 3.5 mmol (1.0 g compound, The title is dissolved in 13 ml of absolute ethanol with heating and an equimolar amount of methanesulfonic acid dissolved in 1 ml of absolute ethanol is added. After cooling, 5 ml of ether are added and after settling, the precipitated crystals are filtered out at room temperature for 12 hours and washed and dried. Thus obtained (N-aM nocarboni amino) ethyl-4- (3-chlorophenyl) piperazine methanesulfonate has a melting point of 1-6.5-1.7.7 C. The 3.4 mmol (0.96 g) of the title compound is dissolved in 15 ml of absolute ethanol by heating and then 1.7 mmol of sulfuric acid (3.22 ml of a 1.059 solution of sulfuric acid in water) is added. The solvents are evaporated under reduced pressure at 50 ° C. The residue is crystallized from ethanol / ether to give (M-aminocarbyl-amino) ethyl 4- (3 chlorophenyl) piperazine sulfate 2: 1 with so pl. 176-177 ° C. Note 4. (VJ-aminocar brylamino) etzl -4- (3-trifluoromethylphenyl) piperazn. The compound was prepared in accordance with the procedure described in Example 3 from 1 (2-aminoethyl) -4- (3-trifto1 letilfeny pkperazine) and it has mp 143-14 3.1 mmol (1.0 g) of the title compound. , dissolve 3 to 3 ml of absolutine ethanol by heating and equimolar amount of 2N alcoholic solution of hydrogen chloride is added. After cooling to room temperature, ether is added until crystallization begins. As a result, N-aminocarb lamino-4 - (3-trifluoromethylphenyl piperazine hydrochloride salt with a melting point of 202203 ° C. 3.1 mmol (1.0 g) of the compound indicated in The solution is dissolved in absolute ethanol with heating, then an equimolar amount of sulfuric acid is added. After cooling, 5 ml of ether are poured, after which the salt crystallizes, to obtain 1- (2-c1 Minocarbolamino) ethyl fluoromethylphenyl) piperazine 1: 1 with a melting point of 150-151 C. In a similar manner, the action of methanesulfonic acid is obtained in 1-; 2- (N-aminocarbolamino) (3-trifluoromethylphenyl) piperazine methanesulfonate, m.p. 183.5-184 C. Pr. And measure 5. (N-aMHHocarbonyl-H-ethyl) aminoethyl-4- (3-tpnn fluoromethylphenyl) piperazine. This compound is prepared as described in Example 3 from 1t2- (N-ethylamino) ethyl-4- (3-trifluoromethylphenyl) piperazine and it has a mp. 136-137C. Example 1- 2-N-acetIshaminoCethyl -4- (3- rifluoromethylphenyl} piperazine. 20 mmol (5.2 g) 1- (2-aminoethyl) 4- (3-trifluoromethylphenyl) piperazine is dissolved in 30 ml of glacial acetic acid and 37.5 mmol (3.8 g) of acetic anhydride are then added and refluxed for 2 hours. The mixture is then evaporated under reduced pressure to dryness. A full solution of sodium bicarbonate in water is added to the residue and twice extracted with 100 ml of methylene chloride. After drying with Kalk carbonate and distilling off the methylene chloride, the residue is crystallized from a toluene / ether mixture to give the compound With mp 85-87s, using the procedure described in example 4, the base obtained is converted into 1- (2- (H-acetylamino) ethyl-4- (3-trifto1) methylphenyl) piperazine methanesulfonate with mp 171 by the action of methanesulfonic acid. , 5-173,. 3.2 mmol (1.0 g) are dissolved in 5 ml of absolute ethanol with heating, then 3.2 mmol (370 mg) of maleic acid are added, then 15 ml of ether, after cooling, crystals precipitate ( S-acetylamino ethyl) (3-trifluorometh1-phenyl | piperazine maleate (1: 1) with m.p. 113-115 ° C. Another base preparation, similar to that described in Example i, 4 is converted by the action of hydrogen chloride in (N-acetylamino) ethyl} -4- (3-trifluoromethylphenyl J piperazine hydrochloride with mp 197-199 p. Example 7. 1- 12- (M-acetylt-ylamino-H-ethyl-4-3 (3-trifluoromethylphenyl) piperazine. 15 mmol (4.5 g), 1 (N-ethylamino) (3-trifluoromethylphenyl) piperazine is dissolved in 30 ml of methylene chloride and added a solution of 15 mmol (1.2 g) of acetyl chloride in 0 ml of methylene chloride is added dropwise at a temperature not higher than 40 C. Then the solution is stirred at a temperature of 30 minutes, the resulting mixture is then drying is carried out on dryness under reduced pressure .. The residue is crystallized from isopropanol and a product is obtained with mp 189181 C. Example 8. 1-f 2- (N-formyls p) (3-chlorophenyl) piperazine 62 mmol (b, 3 ) acetic anhydride and 67 mmol (3.0 g) of formic acid are heated at 50-60 ° C for 2 hours. A solution of 21 mmol of 1- (2-aminoethyl) -4 (3-chlorophenyl) is then added dropwise. piperaein in 15 ppm of absolute tetrahydrofuran, and the addition is carried out at such a rate that the temperature of the mixture does not exceed 45 ° C. After stirring for 12 hours at room temperature, the solvent is distilled off and 16 ml of water and sodium bicarbonate are added (until neutral). Then extracted twice with methylene chloride. After washing with water and drying with potassium carbonate, the solvent was evaporated under reduced pressure. The residue obtained is purified on a chromatographic column filled with silica gel, and a mixture of ethanol and 25% ammonia in a ratio of 95: 5 is used as eluent. The solvents are distilled off under reduced pressure, and the residue is crystallized from ether / petroleum ether to give the product with m.p. b6 Example 9, 1-L2- (N-formyl-no) (3-chlorophenyl) piperazine. 16.7 mmol (4.0) g of 1- (2-aminoethi-1 o4- (3-chlorophenyl 5 piperazine) is dissolved in 20 ml of formic acid and the mixture is stirred for 12 hours at room temperature. Then add 50 ml of water and 50 ml of methylene chloride. The layers are separated and the aqueous layer is extracted again with methylene chloride. The combined organic layers are washed with WATER and dried. The solvent is then removed under reduced pressure. The residue is purified on a column filled with silica gel, and a mixture of methylene chloride / methanol is used in a silica gel 95 : 5. After removing the solvent the residue is crystallized from ether / petroleum ether to give the compound with mp, b6,5-b80c Example 10. (N acetylamino) (3-hlrrphenyl) piperazine 45 mmol (8.7) g 1- (3-chlorophenyl) piperazine, 45 mmol (5.4 g N-acetyl 2-chloroethylamine and 45 mmol (6.2 ml) of triethylamine are mixed and heated at 60-70 ° C for 20 h. Next, 50 ml of 2 h of potassium hydroxide and 100 ml of methylene chloride. The methylene chloride layer is washed with 15 ml of water and then dried with potassium carbonate, the solvent is distilled off under reduced pressure. The residue was purified by chromatography on a column filled with silica gel, and the mixture / methylene chloride / methanol in a ratio of 95: 5 was used as eluent. After evaporation of the solvents, the free base is crystallized from ethyl acetate / petroleum ether to give the product with m.p. 96.5-97.5 ° C. . Using the procedure described in Example 4, a part of the obtained product is converted by the action of hydrogen chloride in (M-acetylamino) (3-hlrrphenyl) piperazine hydrochloride with m.p. 173-175c. Analogously, (M-ace „, tolamino) (3-chlorophenyl) piperazene methanesulfonate with m.p. 171173-s and (N-acetylamino) ethyl7 4- (3-chlorophenyl) piperazine sulfate (1: 1) with m.p. 121.5-124 0. Example 11. (N-acetylamide) (3-trifluoromethylphenyl) piperazine. This compound is prepared using the procedure described in Example 10 from 1- (3-trifluoromethylphenyl) piperazine with m.p. 85-87 ° C, (N-acetylamino) (3-trifluoromethylphenyl) piperazine sulfate (1: 1) has so pl. 119.5-121.5 ° C. Example 12. l-t2- (N-acetyl-methylamino) (3-trifluoromelphenyl piperazine hydrochloride This compound is prepared using the procedure described in example 10, from II 3-trifluoromethylphenyl piperazine and N-acetyl-N-methyl-2- chloroethylamine and further treatment with hydrogen chloride, mp 182-184 C, 1- .2- (N-acetyl-N-methylamino) ethyl 4- (3-trifluoromethylphenyl) piperazine methanesulfonate has a melting point of 123-124 C. (H-acetyl-M-methylamino) ethyl 4- (3-trifluoromethylphenyl) piperazine maleate (1: 1) has a mp of 123-124 ° C, Example 13. (H-acetylamino ethyl-4- (3-fluorophenyl a) piperazine. This compound is obtained using the procedure described in Example 10, from 1- (3-fluorophenyl) piperazine and it has a mp of 97.5-99 ° C. Example 14. (| l-acetylamino} (3-bromophenyl) piperazine) This compound is prepared using the procedure described in Example 10 from 1- (3-bromophenyl) piperazine and it has a mp of 97-98.5 p. Example 15. 1- 24N-acetyl-methylamino) ethyl-4- (3-chlorophenyl) piperazine dihydrochloride monohydrate This compound is obtained according to the method described in Example 10, from 1 (3-chlorophenyl) piperazine and N-acetylK-methyl-2-chloroethylamine, and it has a m.p. 186-19GS, Example 16. 1-G2- (N-aminocarbonylamino) (Z-chlorophenyl) piperazine. 20 mmol, 8 g) 1- (2-aminoethyl) 4 g: (3-chlorophenyl) piperazine is mixed with 20 mmol (1.2 g) of urea and the mixture is heated at 140 s for
    1 h, then crystallized from ethanol and get the connection with so pl. 163164 S ..
    Example 17. 1- 2- {N-acetyl-N -methyl-amino-ethylZ-4- (3-trifluoromethylphenyl piperazine hydrochloride (1: 1)
    5 mmol of sodium hydride (0.24; g) 55% suspension in oil is dissolved in 30 ml of dimethylformamide and 5 mmol (1.6 g) of (C-acetylamino) ethyl -4-3-trifluoromethylphenyl) piperazine is added. . The mixture is stirred for 1 h at 70 ° C. After cooling, 6.6 mmol (o, 92 g) of methyl iodide are added and the mixture is stirred at 2 hours. The mixture is cooled to room temperature and diluted with 100 ml of water. extract twice with portions of 150 ml of methylene chloride. The methylene chloride extracts are washed twice with 25 ml of water, dried with potassium carbonate, and the solvent is evaporated under reduced pressure. The residue is purified by chromatography on a column filled with silica gel using eluant methylene chloride / methanol in a ratio of 25 7: 3. After evaporation of the solvents, the free base is obtained in the form of a gummy product.
    This free base is converted by treatment with hydrogen chloride ... into the title compound, and it has so pl. 182-184 S.
    Pr im ep 18. (K-acetylamino ethyl-4- (3-trifluoromethylphenyl) piperazine.
    40 mmol (2.8 g) of acetamide was added to a suspension of 40 mmol of sodium hydride (1.9 g of a 55% suspension in oil) in 100 ml of dimethylformamide. The mixture is stirred for 1 hour at, cooled to room temperature, and 40 solutions of 46 mmol of 13.6 g of 1- {2-chloroethyl) -4- (3-trifluoromethylphenyl) piperazine in 15 ml of dimethylformamide are added.
    The mixture is stirred for 2 hours at 40 ° C., then cooled to room temperature (45 ° C) and the solvent is evaporated under reduced pressure. Water and methylene chloride were added to the residue. After. separation of the organic extract is dried with potassium carbonate and the solvent is packa, / dated under reduced pressure. The residue is purified by chromatography on a column filled with silica gel, and a mixture of methylene chloride and methanol in a ratio of 95: 5 is used as eluent. After evaporation of the solvents, the resulting free base is crystallized from ethyl acetate / petroleum ether to give the product with mp. 85-87 C.
    Example 19. (N-acetylamino ethyl 3 -4- (3-chlorophenyl) piperaein.
    3.8 mmol (1.0 g) (M-acetylamino) (3-aminophenyl) piperazine is dissolved in 5 ml of 6N. chlorine-65
    hydrochloric acid, cooled before and then diazotized at this temperature with a solution of 4 mmol (0.28 g of sodium nitrite in 2 ml of water .. After keeping for 20 min. the resulting solution is added to a suspension consisting of 4 mmol (0 , 4 g) monovalent copper chloride and a catalytic amount of copper powder in 5 ml of water, at 70 ° C. Next, I is cooled to room temperature and 5 ml of concentrated hydrochloric acid is added.The suspension is stirred for 2 hours and, after cooling, 5 ml of 50% is added a solution of sodium hydroxide. The mixture is thrice ekst The residue is washed with water. The solvent is distilled off under reduced pressure. The residue is purified by chromatography on a column of silica gel using methylene chloride / methanol as the eluent over a 95: 5 distillation. After evaporation of the solvents, the residue is crystallized from ethyl acetate / petroleum ether, get the product with so pl. 96. 5-97 ,.
    Example 20. l-t2 - (- mets) xycarbonylamino) ethyl-4- (3-chlorophenyl) piperazine dihydrochloride.
    Within 10 minutes, 20 mmol (1.8 g) of methyl chloroform is added to a solution of 15 mmol (3.6 g) of 1- (2-aminoethyl) -4- (3-chlorophenyl) piperazine in 40 ml of methylene chloride. After stirring for 1 hour, the mixture was washed twice with 25 ml of 5% sodium bicarbonate solution. The organic layer is dried with potassium carbonate and evaporated to dryness. The free base is treated with two equivalents of hydrogen chloride in absolute ethanol. After adding 100 ml of ether, a precipitate is formed, which is filtered off, dried and a product is obtained with mp. 146.5148 p.
    Example 21. (N-methoxycarbonylamino) ethyl} -4- (3-trifluoromethylphenyl) piperazine hydrochloride.
    A solution of 0.12 mmol (11.3 g) of methyl chloroformate in 60 ml of methylene chloride is added while stirring to a plant with 0.1 mmol (27.3 g) of 1- (2-aminoethyl | 4-Tz-triftoE 1-methylphenyl) piperazine in 400 ml of methylene chloride for 45 minutes and then stirred for another 1 hour at room temperature. After settling for 12 hours, the precipitated product is filtered off. After crystallization from 100 ml of abs. lute ethanol get the product
    60 s. ISB-ISS C.
    Example 22. (N-thioaceclamino) -ethyl-4- (3-trifluoromethylphenyl) piperazine gnecrochloride.
    To a suspension of 10 mmol (s, 15 g1 (AND-acetylamino ethyl 4- (3-trifluoromethylphenyl riperazine and .10 mmol (2.22 g of pentahedral phosphorus in 30 MP of methylene chloride) are added dropwise 40 mmol. (5.12 ml triethylamine, and the mixture is stirred at room temperature. After 24 hours, the mixture is washed with water and then the organic layer is separated and dried with potassium carbonate. The residue obtained after evaporation of the solvent is purified by chromatography on a silica gel using ethnoplacetate as an ingredient. After evaporation of the solvent obtained the free base is treated with an equivalent amount of hydrogen chloride in ethanol.The resulting hydrochloride salt is crystallized and a product is obtained with mp 140-142 ° C.
    Example 23. (M-allophanimine-4-3-trifluoromethylphenyl) piperazine ..
    A solution of 33.7 mmol (9.22 g) of 1 (2-aminoethyl) -4- (3-trifluoromethylphenyl) piperazine and 33.7 mmol (5 g) of nitrobiureTa in 125 ml of water is heated slowly to boiling point. After 1 hour of heating at this temperature and 48 hours at room temperature, the precipitated product is filtered off, dried and crystallized from 30 ml of acetonitrile and 25 ml of ethyl acetate. In the result ;; {XiH «) p-F-e-Bi (0) m Bg T
    Rj
    kch
    Tate receive a product with so pl. 149149, 5 ° C.
    Approximately 24. (M-allopha.-noylamino) ethyl-4- (3-chloromethylphenyl) piperazine.
    This compound is prepared analogously from 1- (2-aminoethyl) -4- (3-chlorophenyl) piperazine as the starting compound. It has a mp. 163-164 ° C.
    EXAMPLE 25 (N acetylamino) ethyl-4- (3-trifluoromethylphenyl) piperazine-1-oxide.
    To a solution of 9.59 mmol (g, 02 g) (N-acetylamino) (3-trifluoromethylphenyl) piperazine in 40 ml of methylene chloride is added dropwise a solution of 9.6 mmol of 3-chloroperbenzoic acid in 15 ml of methylene chloride. 24 hours after the addition of the solution, the mixture was washed twice with 10 ml of 2N. caustic soda and 10 ml of water. The organic layer is dried with potassium carbonate and after evaporation of the solvent and crystallization of the residue, a product with m.p. 1B7.5-169 - p.
    $
    PRIMEREUR 26. 1-t2- (N-aminocarbonyamine) ethyl-4- (3-trifluoromethylphenyl piperazine-1-oxide.
    Similarly, 1- 2- (y-aminocarbonylamino) ethyl-4- (3-trifluoromethylphenyl) piperazine is converted to the corresponding 1-oxide with mp. 192.5-193.5С.
    Ed-re
    权利要求:
    Claims (1)
    [1]
    METHOD FOR PRODUCING NEW PHENYLIPIPERASIN OF GENERAL FORMULA where - hydrogen, methyl, methoxy, ethoxy, amino or ureido group,
    R-ι is hydrogen or Cj [- C ^ alkyl, trifluoromethyl or halogen, tn -O. or 1, characterized in that the amine of the general formula, where they have the indicated meanings, is reacted with formic or acetic acid, or their anhydrides, or their esters, or their amides, or acetic acid halocanhydride, or methoxy- or ethoxyhaloid formate or alkali metal cyanate, or urea, or nitrobiuret, followed by isolation of the target product or its oxidation.
    SU 1039442 A
    类似技术:
    公开号 | 公开日 | 专利标题
    CN105503867B|2019-01-11|The method for being used to prepare the fluoro- 1H- pyrazolo-pyridines of substituted 5-
    US4720493A|1988-01-19|Thienylthiazole compounds
    CA2234619A1|1997-04-17|Substituted heteroaromatic ring derivatives
    JP2008514713A|2008-05-08|Production of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
    CA2504153C|2012-07-03|Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases
    JPH0625134B2|1994-04-06|New heterocyclic compound
    MXPA06001590A|2006-05-19|Process for the preparation of 4-amino-3-quinolinecarbonitriles.
    SU1039442A3|1983-08-30|Process for preparing derivatives of phenylpiperazine
    DE3826846A1|1990-02-08|ALKOXY-4 | -PYRIDONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DRUGS
    RU1802811C|1993-03-15|Method for preparing n-|-n-|-gyanidine or its acid additive salts
    US3502647A|1970-03-24|Perimidine derivatives
    SU479290A3|1975-07-30|The method of obtaining 2- | -6,7 benzomorfan
    DE2737630C2|1987-11-05|
    US5064963A|1991-11-12|Process for the synthesis of n-|phenyl-4-|-2-pyrimidinamines
    SU1033003A3|1983-07-30|Process for preparing derivatives of 4-pyrimidone or their pharmaceutically acceptable acid addition salts
    US3201406A|1965-08-17|Pyridylcoumarins
    US4420476A|1983-12-13|Benzofuro[3,2-c]pyrazol-3-amine derivatives
    US3060192A|1962-10-23|Production of enantiomers of alphamethyl-phenethyl hydrazine and intermediate
    WO2006002764A1|2006-01-12|4-trifluoromethoxyphenoxybenzol-4&#39;-sulfonic acids, method for the production and use thereof in medicaments
    SU1433411A3|1988-10-23|Method of producing derivatives of 2-|-quinolon or pharmaceutically acceptable salts thereof
    SU468423A3|1975-04-25|Method for preparing 6-aza-3n-1,4-benzodiazepines
    US8815870B2|2014-08-26|4-| hydrazinyl)benzonitrile and preparation thereof
    CH460773A|1968-08-15|Process for the preparation of substituted 3- | -1-phenacyl-piperidines
    FI70209C|1986-09-15|PROCEDURE FOR FRAMSTAELLNING AV PYRROLIDIN-2-ONER OCH 3-PYRROLIN-2-ONER
    US6207825B1|2001-03-27|Method for production of pyrrolidinone derivatives
    同族专利:
    公开号 | 公开日
    HU182070B|1983-12-28|
    IL59489D0|1980-05-30|
    ES8200883A1|1981-11-16|
    PL126161B1|1983-07-30|
    DD151408A5|1981-10-21|
    FI800588A|1980-09-02|
    AU532411B2|1983-09-29|
    ES8200884A1|1981-11-16|
    YU54680A|1983-09-30|
    CA1138461A|1982-12-28|
    AT2219T|1983-01-15|
    IE800405L|1980-09-01|
    DE3061561D1|1983-02-17|
    ZA801119B|1981-09-30|
    GR67005B|1981-05-18|
    CS216525B2|1982-11-26|
    JPS55141478A|1980-11-05|
    EP0015615B1|1983-01-12|
    IL59489A|1984-05-31|
    ES495106A0|1981-11-16|
    ES495105A0|1981-11-16|
    AU5584880A|1980-09-04|
    DK84380A|1980-09-02|
    EP0015615A1|1980-09-17|
    ES488988A0|1981-09-01|
    PH17025A|1984-05-17|
    ES8106898A1|1981-09-01|
    PL222294A1|1980-12-01|
    IE49526B1|1985-10-16|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US2833770A|1958-05-06|Chj-chj |
    US2722529A|1955-11-01|Amides of certain l-amevoalkyl-x-phenyl |
    BE788280A|1971-09-04|1973-02-28|Pfizer|NEWS 1- -4 - - ALKYL) PIPERAZINES AND PHARMACEUTICAL COMPOSITION CONTAINING THEM|
    GB1443598A|1973-07-06|1976-07-21|Acraf|1- 3-acetylaminopropyl-4-2,5-dichlorophenyl-piperazine|
    FR2306694B1|1975-04-07|1980-01-04|Parcor|NL8005131A|1980-09-12|1982-04-01|Duphar Int Res|PHENYLPIPERAZINE DERIVATIVES WITH ANALGETIC ACTION.|
    NL8005133A|1980-09-12|1982-04-01|Duphar Int Res|PHENYLPIPERAZINE DERIVATIVES WITH ANTIAGRESSIVE ACTION.|
    US4457931A|1982-09-27|1984-07-03|Selvi & C. S.P.A.|Piperazine derivatives with anticholinergic and/or antihistaminic activity|
    JPH0660160B2|1985-12-13|1994-08-10|テルモ株式会社|Amide derivative and antiallergic agent containing the same|
    US5382583A|1989-04-22|1995-01-17|John Wyeth & Brother, Limited|Piperazine derivatives|
    US5340812A|1989-04-22|1994-08-23|John Wyeth & Brother, Limited|Piperazine derivatives|
    PT93824B|1989-04-22|1996-09-30|Wyeth John & Brother Ltd|PROCESS FOR THE PREPARATION OF PIPERAZINE DERIVATIVES|
    IE65362B1|1989-04-22|1995-10-18|Wyeth John & Brother Ltd|Piperazine derivatives|
    DK203990D0|1990-08-24|1990-08-24|Novo Nordisk As|piperazinyl|
    GB9200293D0|1992-01-08|1992-02-26|Wyeth John & Brother Ltd|Piperazine derivatives|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    NL7901633|1979-03-01|
    [返回顶部]